Protalix BioTherapeutics

PLX

Capitalización de mercado USD 250 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Renaissance Technologies New York	USD 2.54 M	+USD 1.73 M	+985,147	+439%
2	2 Meitav Investment House Bene-Beraq, Israel	USD 494 k	-USD 263	-150	-0.1%
3	3 Citadel Advisors Miami, Florida	USD 444 k	+USD 153 k	+87,241	+70%
4	4 Two Sigma Investments New York	USD 408 k	+USD 323 k	+183,968	+1,817%
5	5 Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada	USD 333 k	+USD 278 k	+158,703	Nuevas
6	6 Marshall Wace London, United Kingdom	USD 316 k	+USD 264 k	+150,358	Nuevas
7	7 Bridgeway Capital Management Houston, Texas	USD 281 k	–	–	–
8	8 BlackRock New York	USD 244 k	+USD 25 k	+14,250	+14%
9	9 Millennium Management New York	USD 182 k	+USD 152 k	+86,698	Nuevas
10	10 Morgan Stanley New York	USD 173 k	+USD 130 k	+73,959	+900%
11	11 Commonwealth Equity Services Waltham, Massachusetts	USD 105 k	–	–	–
12	12 Jane Street New York	USD 83.3 k	-USD 92.2 k	-52,554	-57%
13	13 XTX Topco George Town, Cayman Islands	USD 71.5 k	+USD 59.8 k	+34,064	Nuevas
14	14 IHT Wealth Management Chicago, Illinois	USD 56.3 k	–	–	–
15	CPA 15 Capital Performance Advisors Walnut Creek, California	USD 54.5 k	–	–	–
16	16 CIBC World Market Toronto, Ontario, Canada	USD 52 k	-USD 19.3 k	-11,000	-31%
17	17 Two Sigma Securities New York	USD 43.6 k	+USD 36.4 k	+20,760	Nuevas
18	18 Two Sigma Advisers New York	USD 41.8 k	-USD 1.23 k	-700	-3%
19	19 Sculptor Capital New York	USD 40.1 k	+USD 33.5 k	+19,100	Nuevas
20	20 Aptus Capital Advisors Fairhope, Alabama	USD 33.6 k	+USD 28.1 k	+16,010	Nuevas
21	21 Lido Advisors Los Angeles, California	USD 32.7 k	+USD 27.3 k	+15,554	Nuevas
22	22 Altshuler Shaham Tel Aviv, Israel	USD 25.5 k	-USD 589	-336	-3%
23	23 HRT Financial New York	USD 21 k	+USD 18.1 k	+10,309	Nuevas
24	24 TD Waterhouse Canada Toronto, Ontario, Canada	USD 13.2 k	–	–	–
25	25 National Bank of Canada Montreal, Quebec, Canada	USD 12.7 k	–	–	–

Protalix BioTherapeutics PLX Capitalización de mercado USD 250 M

Protalix BioTherapeutics

PLX

Capitalización de mercado USD 250 M